Anti-MDA5 (melanoma differentiation-associated protein 5) delineates a distinct, often lethal endophenotype [40,41,42,43,44]: rapidly progressive ILD (occurring in 70–90% of anti-MDA5-positive dermatomyositis), cutaneous ulcerations, and vasculopathy. The gene discussed is IFIH1; the disease is dermatomyositis.